Conversely, disrupting the NLRP6‐p85α interaction has been shown to suppress tumor progression.[47] Our findings provide new insights into the modulation of EZH2 degradation in cancer cells and expand the understanding of the intricate relationship between cellular metabolism and epigenetic regulation. This evidence concerns the gene EZH2 and cancer.